Prospective Study on Esophageal and Gastric Endoscopic Submucosal Dissection Using a New Thin Scope EG-840TP

Prospective Study on Esophageal and Gastric Endoscopic Submucosal Dissection Using a New Thin Scope EG-840TP - Study on EG-840TP-ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053484

Enrollment

200

Registered

2024-02-01

Start date

2024-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal and gastric epithelial neoplasms

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing esophageal or gastric ESD at our hospital. Patients who have given their consent to participate in the study on paper. Patients over 18 years old.

Exclusion criteria

Exclusion criteria: Patients who are allergic to propofol, pentazocine, or lidocaine. Patients who are allergic to propofol, pentazocine, or lidocaine. Pregnant or lactating patients.

Design outcomes

Primary

Measure	Time frame
Percentage of patients who complete treatment without changing from EG-840TP to another scope (completion rate).	—

Secondary

Measure	Time frame
Treatment time per site, number of hemostats used, en bloc resection rate, en bloc complete resection rate, scope questionnaire, sedative and analgesic doses during ESD, incidence of adverse events (perforation, posterior hemorrhage).	—

Countries

Japan

Contacts

Public ContactSatoko Kurita

Sendai Open Hospital, Sendai Medical Center Medical office

hisho2@openhp.or.jp022-252-1111

Outcome results